Healthcare & Life Sciences
argenx
Netherlandsargen-x.com
argenx is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About argenx
argenx is a startup based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
argenx SE is a biopharmaceutical company that develops antibody-based therapies focused on treating severe autoimmune diseases using its proprietary Simple Antibody discovery platform.
Explore argenx's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.